ReviewBiomedical optics express2025
Custom-designed Verasonics-based multi-wavelength photoacoustic and ultrasound imaging: from technical advances to preclinical applications in cancer.
Review in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Introduction to the feature issue Photoacoustic Imaging and Sensing: Beyond Fundamentals to Translation.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Real-time multi-wavelength photoacoustic (PA) imaging has emerged as a powerful modality for investigating tumor vascular dynamics, offering non-invasive, high-resolution visualization of hemodynamic changes that are critical for cancer diagnosis and therapeutic monitoring. In this study, we present a custom integration of the Verasonics Vantage ultrasound platform with an optical parametric oscillator (OPO) laser system. The first part of the study provides a comprehensive review of the current literature on PA imaging using the Verasonics system, emphasizing its capabilities, limitations, and adaptability for advanced imaging applications. Building upon this foundation, we introduce a robust framework that leverages the Verasonics system in conjunction with the fast-tuning capabilities of the OPO laser to enable synchronized, multi-wavelength PA imaging. In the second part of the study, we demonstrate selected applications of the developed system, such as multi-wavelength spectral imaging of tumor vasculature and near-real-time monitoring of therapeutic response. These case studies highlight the system's capability to capture dynamic physiological changes and support functional, longitudinal assessments in complex pathological environments. Future directions include the exploration of alternative tunable laser sources and the integration of machine learning algorithms to enhance real-time image reconstruction and spectral unmixing. Collectively, this work establishes a versatile and scalable platform for advancing PA imaging in preclinical and translational cancer research.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.